|
Citizens United for Research in Epilepsy (CURE), is a leading nongovernmental agency fully committed to funding research in epilepsy.
CURE’s investigator-initiated grants program seeks to push the envelope and accelerate promising research leading to disease-modifying breakthroughs for people living with epilepsy. CURE prioritizes highly innovative, risky, paradigm-shifting projects that address CURE’s mission to cure epilepsy, affirming our core belief that the only acceptable final goal is “no seizures, no side-effects.”
CURE strongly encourages multidisciplinary, collaborative projects, especially those that include investigators and expertise from fields outside of epilepsy.
2017 Priority areas
Transformative research to enhance our understanding of the cellular, molecular, genetic and systems-level mechanisms that lead to any of the epilepsies, facilitating the continued investigation of disease-modifying or preventative strategies
Innovative approaches that can prevent, modify and/or arrest the development of acquired epilepsy after stroke, tumor, viral infection, etc.*
Research that will inform the development of novel therapies to prevent onset or halt the progression of the severe pediatric epilepsies
Research focused on new, effective treatments for the >30% of the epilepsy population who are pharmacoresistant
Novel research that furthers our understanding of the causes and ultimate elimination of SUDEP
*Due to the exciting launch of our Post-Traumatic Epilepsy Team Science Initiative in collaboration with the Department of Defense, this priority area has been slightly revised to exclude epilepsy as a result of head injury.
Based on CURE’s current research objectives, lower priority will be given for research in the following areas:
Research that focuses solely on a comorbid condition without also seeking to address/understand the accompanying epilepsy
Research that focuses solely on improving localization of the epileptic seizure focus
|
